Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of Ottawa

$105,000.00

NAD+ depletion as a cause of placental dysfunction in preeclampsia

FY 2018-19

Summary
Preeclampsia (PE) is a life-threatening hypertensive disorder of pregnancy with no cure. The disease can occur in three forms, one of which is inflammation driven (hyperactive immune response). We have a very limited understanding of this unique subclass of PE which makes it difficult to treat. The purpose of my study is to better understand the underlying cause of this subclass of PE disease. Based on our previous research findings we speculate that placental dysfunction in this subclass of PE occurs by a hyperactive immune response that can deplete the placenta of organelles used to maintain cellular energy (mitochondria). Consequently, the placenta fails to generate the energy required to deliver essential nutrients and oxygen to the fetus. Thus, I will be testing the therapeutic potential of medications that can boost cellular energy signals to improve placenta cell function and overall placenta health. Therefore, findings from this study may contribute to the development of subclass-specific therapy for this group of patients.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
408165
Name
Jahan Fahmida
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
NAD+ depletion as a cause of placental dysfunction in preeclampsia
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Inflammation,; Mitochondria; Nad+; Parp; Placenta; Preeclampsia; Pregnancy; Sirtuin
Abstract
Preeclampsia (PE) is a life-threatening hypertensive disorder of pregnancy with no cure. The disease can occur in three forms, one of which is inflammation driven (hyperactive immune response). We have a very limited understanding of this unique subclass of PE which makes it difficult to treat. The purpose of my study is to better understand the underlying cause of this subclass of PE disease. Based on our previous research findings we speculate that placental dysfunction in this subclass of PE occurs by a hyperactive immune response that can deplete the placenta of organelles used to maintain cellular energy (mitochondria). Consequently, the placenta fails to generate the energy required to deliver essential nutrients and oxygen to the fetus. Thus, I will be testing the therapeutic potential of medications that can boost cellular energy signals to improve placenta cell function and overall placenta health. Therefore, findings from this study may contribute to the development of subclass-specific therapy for this group of patients.
Competitiondate
201810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Jahan, Fahmida
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~
University of Ottawa - $105,000 Grant (2018-19) | Canada Spends